Avrio Capital leads $2.25 mln Series A funding of FODY Food

FODY Food Co has secured $2.25 million in a Series A financing. Aviro Capital, a Canadian food and agriculture venture capital firm, led the round, giving Managing Director Aki Georgacacos a seat on the board. Jonathan Ross Goodman, President and CEO of Knight Therapeutics Inc, also invested. Launched last year by CEO Steven Singer, Montréal-based FODY develops and makes low FODMAP food products for people suffering from irritable bowel syndrome (IBS). It will use the funds raised to accelerate its U.S. and Canadian online and retail distribution and develop new products. Singer previously led Claridge-backed Glutino Inc.

CanadaNorth AmericaBriefs